Oslo ,March 6, 2024 -Observe Medical ("the Company" or "Observe Medical ") will release its results for the second half and full year 2023 on Wednesday,13 March 2024 . The presentation will be published onNewsWeb and theCompany's website at07:00 CET on the same day. The Company will host a presentation and Q&Asession at08:30 CET on the same day. Personal attendance is welcomed at Olav Vs gate 5, 0161 Oslo (https://www.google.com/maps/place/data=!4m2!3m1!1s0x46416e80b0b4d189:0x542 7 c113c334e02e?sa=X&ved=2ahUKEwjAx9nap86EAxVZIxAIHc_WAg4Q4kB6BAhFEAA). The session will also be streamed via webcast. To register and follow the presentation online, please copy and paste the following link into your browser, click attend and register your e-mail: https://channel.royalcast.com/hegnarmedia/#!/hegnarmedia/20240313_1 After the live event, the presentation and recording will be made availableunder the Investor Relations section on the Company's website, https://observemedical.com/investor-relations/ For further information, please contact: Jørgen Mann, Interim CEOObserve Medical Mobile: +45 408 67558 E-mail: jorgen.mann@observemedical.comJohan Fagerli , Finance Manager Observe Medical Mobile: +47 958 12765 E-mail: johan.fagerli@observemedical.com AboutObserve Medical Observe Medical is a Nordic medtech company that develops, markets and sells innovative medtech products for the global market. The Company is committed to improving patient welfare and patient outcomes, improving clinical data accuracy and promoting positive health economics. The Company seeks to drive growth by leveraging its expertise in sales and commercialization of its broad portfolio of medical technology products, mainly in urine measurement, ultrasound, anesthesiology/ICUs, surgery and wound care, in combination with targeted M&A. The Company is headquartered inOslo, Norway , with additional offices in Narvik,Norway andGothenburg, Sweden , and subsidiaries inFinland and the US. In addition,Observe Medical has a direct sale organization in the Nordics and a distributor network internationally. Further information is available atwww.observemedical.com.
Click here for more information
© Oslo Bors ASA, source